203 related articles for article (PubMed ID: 35706980)
1. Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host.
Caccuri F; Messali S; Bortolotti D; Di Silvestre D; De Palma A; Cattaneo C; Bertelli A; Zani A; Milanesi M; Giovanetti M; Campisi G; Gentili V; Bugatti A; Filippini F; Scaltriti E; Pongolini S; Tucci A; Fiorentini S; d'Ursi P; Ciccozzi M; Mauri P; Rizzo R; Caruso A
Virus Evol; 2022; 8(1):veac042. PubMed ID: 35706980
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
Nchioua R; Schundner A; Kmiec D; Prelli Bozzo C; Zech F; Koepke L; Graf A; Krebs S; Blum H; Frick M; Sparrer KMJ; Kirchhoff F
J Virol; 2022 Jun; 96(11):e0059422. PubMed ID: 35543509
[TBL] [Abstract][Full Text] [Related]
3. IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication.
Meischel T; Fritzlar S; Villalon-Letelier F; Tessema MB; Brooks AG; Reading PC; Londrigan SL
J Virol; 2021 Sep; 95(20):e0083721. PubMed ID: 34319159
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.
Sun F; Wang X; Tan S; Dan Y; Lu Y; Zhang J; Xu J; Tan Z; Xiang X; Zhou Y; He W; Wan X; Zhang W; Chen Y; Tan W; Deng G
Microbiol Spectr; 2021 Sep; 9(1):e0026121. PubMed ID: 34346744
[TBL] [Abstract][Full Text] [Related]
5. Intra-host evolution during SARS-CoV-2 prolonged infection.
Voloch CM; da Silva Francisco R; de Almeida LGP; Brustolini OJ; Cardoso CC; Gerber AL; Guimarães APC; Leitão IC; Mariani D; Ota VA; Lima CX; Teixeira MM; Dias ACF; Galliez RM; Faffe DS; Pôrto LC; Aguiar RS; Castiñeira TMPP; Ferreira OC; Tanuri A; de Vasconcelos ATR
Virus Evol; 2021 Sep; 7(2):veab078. PubMed ID: 34642605
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 evolution during prolonged infection in immunocompromised patients.
Marques AD; Graham-Wooten J; Fitzgerald AS; Sobel Leonard A; Cook EJ; Everett JK; Rodino KG; Moncla LH; Kelly BJ; Collman RG; Bushman FD
mBio; 2024 Mar; 15(3):e0011024. PubMed ID: 38364100
[TBL] [Abstract][Full Text] [Related]
7. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
[TBL] [Abstract][Full Text] [Related]
8. Opposing activities of IFITM proteins in SARS-CoV-2 infection.
Shi G; Kenney AD; Kudryashova E; Zhang L; Hall-Stoodley L; Robinson RT; Kudryashov DS; Compton AA; Yount JS
bioRxiv; 2020 Aug; ():. PubMed ID: 32803197
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.
Borges V; Isidro J; Cunha M; Cochicho D; Martins L; Banha L; Figueiredo M; Rebelo L; Trindade MC; Duarte S; Vieira L; Alves MJ; Costa I; Guiomar R; Santos M; Cortê-Real R; Dias A; Póvoas D; Cabo J; Figueiredo C; Manata MJ; Maltez F; Gomes da Silva M; Gomes JP
mSphere; 2021 Aug; 6(4):e0024421. PubMed ID: 34319130
[TBL] [Abstract][Full Text] [Related]
10. Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies.
Vellas C; Del Bello A; Debard A; Steinmeyer Z; Tribaudeau L; Ranger N; Jeanne N; Martin-Blondel G; Delobel P; Kamar N; Izopet J
Clin Microbiol Infect; 2022 Jan; 28(1):139.e5-139.e8. PubMed ID: 34537363
[TBL] [Abstract][Full Text] [Related]
11. Immune System Deficiencies Do Not Alter SARS-CoV-2 Evolutionary Rate but Favour the Emergence of Mutations by Extending Viral Persistence.
Manuto L; Bado M; Cola M; Vanzo E; Antonello M; Mazzotti G; Pacenti M; Cordioli G; Sasset L; Cattelan AM; Toppo S; Lavezzo E
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543811
[TBL] [Abstract][Full Text] [Related]
12. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
13. Relevance of the Entry by Fusion at the Cytoplasmic Membrane vs. Fusion After Endocytosis in the HIV and SARS-Cov-2 Infections.
Huerta L; Gamboa-Meraz A; Estrada-Ochoa PS
Results Probl Cell Differ; 2024; 71():329-344. PubMed ID: 37996685
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
15. Host-dependent editing of SARS-CoV-2 in COVID-19 patients.
Gregori J; Cortese MF; Piñana M; Campos C; Garcia-Cehic D; Andrés C; Abril JF; Codina MG; Rando A; Esperalba J; Sulleiro E; Joseph J; Saubí N; Colomer-Castell S; Martin MC; Castillo C; Esteban JI; Pumarola T; Rodriguez-Frias F; Antón A; Quer J
Emerg Microbes Infect; 2021 Dec; 10(1):1777-1789. PubMed ID: 34402744
[TBL] [Abstract][Full Text] [Related]
16. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
[TBL] [Abstract][Full Text] [Related]
17. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
[TBL] [Abstract][Full Text] [Related]
18. Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host.
Sonnleitner ST; Prelog M; Sonnleitner S; Hinterbichler E; Halbfurter H; Kopecky DBC; Almanzar G; Koblmüller S; Sturmbauer C; Feist L; Horres R; Posch W; Walder G
Nat Commun; 2022 May; 13(1):2560. PubMed ID: 35538074
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.
Quaranta EG; Fusaro A; Giussani E; D'Amico V; Varotto M; Pagliari M; Giordani MT; Zoppelletto M; Merola F; Antico A; Stefanelli P; Terregino C; Monne I
Int J Infect Dis; 2022 Sep; 122():444-448. PubMed ID: 35724829
[TBL] [Abstract][Full Text] [Related]
20. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2.
Shi G; Chiramel AI; Li T; Lai KK; Kenney AD; Zani A; Eddy AC; Majdoul S; Zhang L; Dempsey T; Beare PA; Kar S; Yewdell JW; Best SM; Yount JS; Compton AA
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36264642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
